Flush with more than $40 million in capital, Triad integrated research organization Javara says it’s getting ready to “revolutionize” the quality of clinical trials and, ultimately, patient outcomes.
Flush with more than $40 million in capital, Triad clinical research firm Javara says it’s getting ready to “revolutionize” the quality of clinical trials and, ultimately, patient outcomes.
Dr. Rochelle Walensky discusses CDC’s response to the COVID-19 pandemic, CDC’s role in coordinating global health initiatives, and the future of public health in the United States.